Richard C. Pasternak, Director at Milestone Pharmaceuticals Inc. (MIST), bought 10,000 shares at $5.20 ($52K) on 2022-10-20, disclosed to the SEC on 2022-10-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.